-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
With MiMedx Group, Inc.'s (NASDAQ:MDXG)) Price Down 14% This Week, Insiders Might Find Some Solace Having Sold US$1.7m Worth of Shares Earlier This Year.
With MiMedx Group, Inc.'s (NASDAQ:MDXG)) Price Down 14% This Week, Insiders Might Find Some Solace Having Sold US$1.7m Worth of Shares Earlier This Year.
By selling US$1.7m worth of MiMedx Group, Inc. (NASDAQ:MDXG) stock at an average sell price of US$4.17 over the last year, insiders seemed to have made the most of their holdings. After the stock price dropped 14% last week, the company's market value declined by US$57m, but insiders were able to mitigate their losses.
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
Check out our latest analysis for MiMedx Group
The Last 12 Months Of Insider Transactions At MiMedx Group
Over the last year, we can see that the biggest insider sale was by the insider, Timothy Wright, for US$420k worth of shares, at about US$3.75 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$2.96. So it may not shed much light on insider confidence at current levels.
In the last year MiMedx Group insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
NasdaqCM:MDXG Insider Trading Volume September 22nd 2022If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
MiMedx Group Insiders Are Selling The Stock
The last three months saw significant insider selling at MiMedx Group. Specifically, insiders ditched US$302k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.
Does MiMedx Group Boast High Insider Ownership?
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. From our data, it seems that MiMedx Group insiders own 1.9% of the company, worth about US$6.3m. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
So What Do The MiMedx Group Insider Transactions Indicate?
Insiders sold stock recently, but they haven't been buying. And even if we look at the last year, we didn't see any purchases. When you combine this with the relatively low insider ownership, we are very cautious about the stock. So we'd only buy after very careful consideration. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing MiMedx Group. At Simply Wall St, we found 2 warning signs for MiMedx Group that deserve your attention before buying any shares.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
通过出售价值170万美元的MiMedx集团公司纳斯达克(Sequoia Capital:MDXG)股票过去一年的平均售价为4.17美元,内部人士似乎充分利用了所持股份。在上周股价下跌14%后,该公司市值缩水5700万美元,但内部人士能够减轻他们的损失。
尽管我们不认为股东应该简单地跟踪内幕交易,但我们确实认为,密切关注内部人士的所作所为是完全合乎逻辑的。
查看我们对MiMedx集团的最新分析
MiMedx集团过去12个月的内幕交易
过去一年,我们可以看到,最大的内幕出售是内部人士蒂莫西·赖特,以每股3.75美元的价格购买了价值42万美元的股票。我们通常不喜欢看到内幕销售,但售价越低,我们就越担心。令人欣慰的是,这次出售的价格远远高于目前2.96美元的股价。因此,在目前的水平上,这可能不会让人对内部人士的信心有太多了解。
去年,MiMedx集团内部人士没有购买任何公司股票。下面的图表显示了过去一年的内幕交易(按公司和个人)。如果你点击图表,你可以看到所有的个人交易,包括股票价格、个人和日期!
纳斯达克:MDXG内幕交易量2022年9月22日如果你像我一样,你会的不想怀念这一切吗?免费内部人士正在收购的成长型公司名单。
MiMedx集团内部人士正在出售股票
在过去的三个月里,MiMedx集团出现了大量的内幕销售。具体地说,内部人士在那段时间抛售了价值302K美元的股票,我们没有记录任何买入。有鉴于此,很难辩称所有内部人士都认为这些股票很划算。
MiMedx集团是否拥有高度的内部人持股?
我喜欢看内部人士在一家公司持有多少股份,以帮助我了解他们与内部人士的关系。内部人持股比例较高往往会让公司领导层更加关注股东利益。从我们的数据来看,MiMedx集团内部人士似乎持有该公司1.9%的股份,价值约630万美元。总体而言,这种所有权水平并不令人印象深刻,但肯定比什么都没有好!
那么,MiMedx Group Insider交易表明了什么?
内部人士最近卖出了股票,但他们一直没有买入。即使我们看看去年,我们也没有看到任何购买。当你把这一点与相对较低的内部人士持股比例结合在一起时,我们对这只股票非常谨慎。所以我们是经过深思熟虑才会买的。除了了解正在进行的内幕交易外,识别MiMedx集团面临的风险也是有益的。在Simply Wall St.,我们发现MiMedx集团的2个警告标志在购买任何股票之前,这些都值得你关注。
当然了,如果你把目光投向别处,你可能会发现这是一笔很棒的投资。所以让我们来看看这个免费有趣的公司名单。
就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前负责公开市场交易和私人处置,但不包括衍生品交易。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧